Drug Detail
Information about Avelumab + Axitinib
Generic Name |
Avelumab + Axitinib | |
|---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
Pfizer | |
Drug Type |
||
Delivery |
Intravenous, Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
||
Strategy |
||
Drug Category |
PD-L1 + KIT inhibitor | |
Links |
|
Trials of this drug |
|
|
C |
Trial results |
|
| ESMO September 2024 Axitinib plus avelumab in Advanced GIST | |
Search for this drug/combination in: